Natriuretic Peptide Levels and Clinical Outcomes Among Patients Hospitalized With Coronavirus Disease 2019 Infection
OBJECTIVES:. There is increasing evidence of cardiovascular morbidity associated with severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019). Pro-B-type natriuretic peptide is a biomarker of myocardial stress, associated with various respiratory and cardiac outcomes. We hypothesi...
Main Authors: | M. Imran Aslam, MD, Anum Minhas, MD, Anahita Ghorbani, MD, MPH, Julie K. Shade, BS, Vivek Jani, BS, MS, Steven Hsu, MD, Kavita Sharma, MD, Daniela Cihakova, MD, PhD, Allison G. Hays, MD, Nisha A. Gilotra, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2021-07-01
|
Series: | Critical Care Explorations |
Online Access: | http://journals.lww.com/10.1097/CCE.0000000000000498 |
Similar Items
-
Art of prevention: Life in the time of coronavirus
by: Mohsen Baghchechi, BS, et al.
Published: (2020-06-01) -
Racial Differences in Delivery Outcomes Among Women With Peripartum Cardiomyopathy
by: Ellise T. Gambahaya, MD, et al.
Published: (2022-04-01) -
Association of Brain Natriuretic Peptide Levels at Time of Injury with Morbidity and Mortality in Patients with Surgically Treated Hip Fractures
by: Brian Joseph Page, MD, et al.
Published: (2023-06-01) -
Our Experiences with Plastic and Reconstructive Surgery Procedures during Coronavirus Disease 2019 Pandemic
by: Zhichao Wang, MD, MPH, et al.
Published: (2020-05-01) -
Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation
by: Yusuke Ochiumi, MD, et al.
Published: (2015-10-01)